Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse,Rat |
Host species | Rabbit |
Applications | ELISA,WB-Ce |
Brand: | Abnova |
Reference: | PAB7881 |
Product name: | BRAF polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic peptide of BRAF . |
Gene id: | 673 |
Gene name: | BRAF |
Gene alias: | B-RAF1|BRAF1|FLJ95109|MGC126806|MGC138284|RAFB1 |
Gene description: | v-raf murine sarcoma viral oncogene homolog B1 |
Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human BRAF . |
Form: | Liquid |
Recommend dilutions: | ELISA (1:2000) Western Blot (1:500) The optimal working dilution should be determined by the end user. |
Storage buffer: | In PBS (50% glycerol, 1 mg/mL BSA, 0.05% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Human |
Specificity: | This sequence has high homology with similar regions in rat and mouse B-Raf, and has low homology to other Raf family members. |
Reactivity: | Human,Mouse,Rat |
Application image: | ![]() |
Application image note: | Western blot of human Jurkat cells treated with calyculin A (100 nM) for 30 min. The blots were untreated (lane 1) or treated (lane 2) with lambda phosphatase and probed with BRAF polyclonal antibody (Cat # PAB7881). |
Applications: | ELISA,WB-Ce |
Shipping condition: | Dry Ice |
Publications: | BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA. Cancer Res. 2004 Oct 1;64(19):7099-109. |